Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Oxymetazoline (0.025% w/v)
Therapeutic Category
Respiratory, Cold and Cough, ENT
Dosage Form
Drop/Spay
Packaging Type
bottle
Packaging
10ml
Price
₹70/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Oxyniff P Drop containing Oxymetazoline (0.025% w/v) is a topical nasal decongestant designed to relieve nasal congestion caused by colds, allergies, or sinusitis. Oxymetazoline works by constricting blood vessels in the nasal passages, thereby reducing swelling and allowing for easier airflow. This product provides fast and effective relief from nasal stuffiness, helping to clear blocked nasal passages and making breathing easier.
The effects of Oxyniff P Drop are typically felt within minutes, offering relief that lasts for several hours. This makes it especially useful for individuals experiencing short-term nasal congestion due to a cold or seasonal allergic rhinitis. The spray formulation ensures direct application to the nasal passages for fast relief.
Possible side effects include temporary stinging or burning in the nose, dryness, sneezing, or an increased sensation of congestion when overused.
Oxyniff P Drop is indicated for the relief of nasal congestion associated with colds, allergies, and sinusitis.
Do not use for more than 3 consecutive days to avoid rebound congestion. Consult a healthcare provider if symptoms persist.
Store at room temperature in a cool, dry place, away from direct sunlight. Keep the container tightly closed and out of the reach of children.
Composition : Xylometazoline (0.05% w/v)
Composition : Xylometazoline (0.01% w/v)
Composition : Phenylephrine (5mg) + Chlorpheniramine Maleate (2mg) + Dextromethorphan Hydrobromide (10mg)
Composition : Chlorpheniramine Maleate (2mg) + Phenylephrine (5mg) (Banned)
Composition : Chlorpheniramine Maleate (1mg) + Paracetamol (125mg) + Phenylephrine (2.5mg)
Composition : Chlorpheniramine Maleate (2mg) + Paracetamol (250mg) + Phenylephrine (5mg)
Composition : Chlorpheniramine Maleate (1mg) + Paracetamol (125mg) + Phenylephrine (5mg)
Composition : Chlorpheniramine Maleate (2mg) + Phenylephrine (5mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Oxymetazoline 0.025% w/v Nasal Spray is a topical nasal decongestant formulation used for the relief of nasal congestion caused by common cold, allergic rhinitis, sinusitis, upper respiratory tract infections, and nasal blockage in children (as per pediatric strength usage). It works by constricting nasal blood vessels, reducing swelling and improving airflow. It is a valuable ENT and respiratory care segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from ENT specialists, pediatricians, general physicians, and pharmacies. Nasal congestion is a very common condition in all seasons, ensuring steady prescriptions, repeat demand, and strong retail movement across both urban and rural markets.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the ENT, respiratory, and anti-allergy segments with monopoly rights, quality manufacturing standards, attractive packaging, promotional support, and reliable supply services for distributors and medical agencies.
Wholesalers and healthcare suppliers benefit from high seasonal demand during cold and allergy outbreaks, strong OTC and prescription movement, pediatric and adult usage base, and continuous pharmacy sales, making it a stable and fast-moving pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in ENT and respiratory care formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the nasal and allergy care segment.